跳至主要内容
临床试验/JPRN-jRCT1080223849
JPRN-jRCT1080223849尚未招募Unknown

Investigation of the clinical safety and efficacy of favipiravir (Avigan tablets) in patients with novel or re-emerging influenza virus infections

FUJIFILM Toyama Chemical Co., Ltd. (Former Toyama Chemical Co., Ltd.)0 个研究点开始时间: 2018年3月20日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • novel or re-emerging influenza infections who take favipiravir (Avigan tablets) and any gender welcome.

排除标准

  • Pregnant women or women suspected of being pregnant
  • Patients with known hypersensitivity to favipiravir or any of its excipients

研究者

发起方
FUJIFILM Toyama Chemical Co., Ltd. (Former Toyama Chemical Co., Ltd.)

相似试验